Vanishing Bile Duct Syndrome

Clinics in Liver Disease

Volumn 12, Issue 1, 2008, Pages 203-217

  Reau, Nancy S ^a   Jensen, Donald M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMETAZINE; AJMALINE; AMINEPTINE; AMITRIPTYLINE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; BILE ACID; CARBAMAZEPINE; CARBUTAMIDE; CELL NUCLEUS RECEPTOR; CHLOROTHIAZIDE; CHLORPROMAZINE; CHOLERETIC AGENT; CIMETIDINE; CLINDAMYCIN; COTRIMOXAZOLE; CROMOGLYCATE DISODIUM; CYAMEMAZINE; CYPROHEPTADINE; DIAZEPAM; ERYTHROMYCIN; ESTRADIOL; IMMUNOSUPPRESSIVE AGENT; MITOCHONDRION ANTIBODY; TOXIN; UNINDEXED DRUG; URSODEOXYCHOLIC ACID;

ANATOMY; BILE ACID METABOLISM; BILE DUCT; BILE DUCT DISEASE; CHOLANGITIS; CHOLESTASIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; EMBRYO DEVELOPMENT; EMBRYOLOGY; GENETIC DISORDER; HODGKIN DISEASE; HUMAN; IDIOPATHIC ADULTHOOD DUCTOPENIA; INFECTION; ISCHEMIA; MEDICAL LITERATURE; ORGANOGENESIS; PATHOLOGY; PATHOPHYSIOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; TRANSPLANTATION; VANISHING BILE DUCT SYNDROME; VIRUS INFECTION;

BILE DUCTS, INTRAHEPATIC; CHOLESTASIS, INTRAHEPATIC; HUMANS;

EID: 38749119374     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2007.11.007     Document Type: Review

References (53)

1. Ludwig J., Wiesner R.H., and LaRusso N.F. Idiopathic adulthood ductopenia. J Hepatol 7 (1988) 193-199
2. Nakanuma Y., Tsuneyama K., and Harada K. Pathology and pathogenesis of intrahepatic bile duct loss. J Hepatobiliary Pancreat Surg 8 4 (2001) 303-315
3. Guebel A.P., and Sempoux C.L. Drug and toxin-induced bile disorders. J Gastroenterol Hepatol 15 (2000) 1232-1238
4. Moore K.L. The digestive system in the developing human. Clinically oriented embryology. 4th edition (1988), WB Saunders, Philadelphia
5. Clotman F., Libbrecht L., Gresh L., et al. Hepatic artery malformations associated with a primary defect in intrahepatic bile duct development. J Hepatol 39 5 (2003) 686-692
6. Holund B., Poulsen H., and Schlichting P. Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. Scand J Gastroenterol 15 (1980) 329-335
7. Ludwig J., Wiesner R.H., Batts K.P., et al. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology 7 (1987) 476-483
8. Ludwig J. Idiopathic adulthood ductopenia: an update. Mayo Clin Proc 73 (1998) 285-291
9. Kahn E., Markowitz J., Aiges H., et al. Human ontogeny of the bile duct to portal space ration: clinical and laboratory findings in 10 cases. J Pediatr Gastroenterol Nutr 24 (1997) 44-48
10. Alagille D., Estrada A., Hadchouel M., et al. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J Pediatr 110 (1987) 195-200
11. Li L., Krantz I.D., Deng Y., et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 16 (1997) 243-251
12. O'Reilly K., Ahmed S.F., Murday V., et al. Biliary hypoplasia in Williams syndrome. Arch Dis Child 91 (2006) 420-421
13. Woolf G.M., and Vierling J.M. Disappearing intrahepatic bile ducts: the syndromes and their mechanisms. Semin Liver Dis 13 (1993) 261-275
14. Kita H., Matsumura S., He X.S., et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 109 (2002) 1231-1240
15. Colucci G., Schaffner F., and Paronetto F. In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis. Clin Immunol Immunopathol 41 (1986) 35-42
16. Lacerda M.A., Ludwig J., Dickson E.R., et al. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol 90 (1995) 247-249
17. Vierling J.M., and Howell C.D. Disappearing bile ducts: immunologic mechanisms. Hosp Pract (1990) 141-150
18. Wee A., and Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?. Ann Intern Med 102 (1985) 581-587
19. Ludwig J. Small-duct primary sclerosing cholangitis. Semin Liver Dis 11 (1991) 11-17
20. Murphy J.R., Sjogren M.H., Kikendall J.W., et al. Small bile duct abnormalities in sarcoidosis. J Clin Gastroenterol 12 (1990) 555-561
21. Agostini C., Adami F., and Semenzato G. New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol 12 (2000) 71-76
22. Thompson P.P.P., Pitt H.A., Lewin K.J., et al. Sclerosing cholangitis and histiocytosis X. Gut 25 (1984) 526-530
23. Sherlock S. The syndrome of disappearing intrahepatic bile ducts. Lancet (1987) 493-496
24. Liangpunsakul S., Kwo P., and Koukoulis G.K. Hodgkin's diseases presenting as cholestatic hepatitis with prominent ductal injury. Eur J Gastroenterol Hepatol 14 (2002) 323-327
25. Ozkan A., Yoruk A., Celkan T., et al. The vanishing bile duct syndrome in a child with Hodgkin disease. Med Pediatr Oncol 36 3 (2001) 398-399
26. Hubscher S.G., Lumley M.A., and Elias E. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hepatology 17 (1993) 70-77
27. Dich N.H., Goodman Z.D., and Klein M.A. Hepatic involvement in Hodgkin's disease. Cancer 64 (1989) 2121-2126
28. Kim W.R., Ludwig J., and Lindor K.D. Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol 95 (2000) 1130-1138
29. Lefkowitch J.H., Schiff E.R., Davis G.L., et al., (Hepatitis Interventional Therapy Group). Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology 104 (1993) 595-603
30. Delladetsima J.K., Makris F., Psichogiou M., et al. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection. Liver 21 2 (2001) 81-88
31. Kikuchi K., Miyakawa H., Abe K., et al. Vanishing bile duct syndrome associated with chronic EBV infection. Dig Dis Sci 45 (2000) 160-165
32. Levy C., and Lindor K. Drug-induced cholestasis. Clin Liver Dis 7 (2003) 311-330
33. Velayudham L.S., and Farrell G.C. Drug-induced cholestasis. Expert Opin Drug Saf 2 3 (2003) 287-304
34. Choi S.H., Yang S.H., Song Y.B., et al. [A case of vanishing bile duct syndrome associated with hypersensitivity to allopurinol]. Korean J Hepatol 11 (2005) 80-85 [in Korean]
35. Capra F., Nicolini N., Morana G., et al. Vanishing bile duct syndrome and inflammatory pseudotumor associated with a case of anabolic steroid abuse. Dig Dis Sci 50 8 (2005) 1535-1537
36. Srivastava M., Perez-Atayde A., and Jonas M. Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child. Gastroenterology 115 (1998) 743-746
37. Taghian M., Tran T.A., Bresson-Hadni S., et al. Acute vanishing bile duct syndrome after ibuprofen therapy in a child. J Pediatr 145 2 (2004) 273-276
38. Hautekeete M.L., Horsmans Y., Van Waeyenberge C., et al. HLA association of amoxicillin-clavulanate-induced hepatitis. Gastroenterology 117 (1999) 1181-1186
39. Desmet V.J. Vanishing bile duct syndrome in drug-induced liver disease. J Hepatol 26S (1997) 31-35
40. Burak K.W., Pearson D.C., Swain M.G., et al. Familial idiopathic adulthood ductopenia: a report of five cases in three generations. J Hepatol 32 (2000) 159-163
41. Theise N.D., Saxena R., Portmann B.C., et al. The canals of Hering and hepatic stem cells in humans. Hepatology 30 (1999) 1425-1433
42. Roskams T., Theise N.D., Balabaud C., et al. Nomenclature of the finer branches of the biliary tree: canals, ductules and ductular reaction in human livers. Hepatology 39 (2004) 1739-1745
43. Van den Heuven M.C., de Jong K.P., Boot M., et al. Preservation of bile ductules mitigates bile duct loss. Am J Transplant 6 (2006) 2660-2671
44. Van den Heuvel M.C., De Jong K.P., van der Horts M.L., et al. Impaired regeneration of biliary cells in human chronic liver allograft rejection. Special emphasis on the role of the finest branches of the biliary tree. Liver Transpl 10 (2004) 28-35
45. Saxena R., Hytiroglou P., Thung S.N., et al. Destruction of canals of Hering in primary biliary cirrhosis. Hum Pathol 33 (2002) 983-988
46. Van dn Heuvel M.C., Gouw A.S.H., Boot M., et al. The finest branches of the biliary tree might induce biliary vascularization necessary for biliary regeneration. J Hepatol 44 (2006) 947-955
47. Moreno A., Carreno V., Cano A., et al. Idiopathic biliary ductopenia in adults without symptoms of liver disease. N Engl J Med 336 (1997) 835-838
48. Boyer J.L. New perspectives for the treatment of cholestasis: lessons from basic science applied clinically. J Hepatol 46 (2007) 365-371
49. Hagey L.R., Crombie D.L., Espinosa E., et al. Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores. J Lipid Res 34 (1993) 1911-1917
50. Pusl T., and Beuers U. Ursodeoxycholic acid treatment of vanishing bile duct syndromes. World J Gastroenterol 12 (2006) 3487-3495
51. Lazaridis K.N., Gores G.J., and Lindor K.D. Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders. J Hepatol 35 (2001) 134-146
52. Smith L.A., Ignacio J.R., Winesett M.P., et al. Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid. J Pediatr Gastroenterol Nutr 41 4 (2005) 469-473
53. O'Brien C.B., Shields D.S., Saul S.H., et al. Drug-induced vanishing bile duct syndrome: response to ursodiol. Am J Gastroenterol 91 7 (1996) 1456-1457